Valuation: Cenra Inc.

Market Cap 4.99B 157M 137M 129M 117M 220M 15.04B 221M 1.55B 597M 7.65B 589M 576M 24.61B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.25B 228M 199M 187M 170M 319M 21.85B 320M 2.25B 867M 11.11B 855M 836M 35.74B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.49%
Yield 2024
2.72%
Yield 2025 3.01%
1 day+2.24%
1 week+1.18%
Current month-1.58%
1 month-4.99%
3 months-1.30%
6 months+3.01%
Current year+2.54%
1 week 33.5
Extreme 33.5
34.25
1 month 33.5
Extreme 33.5
36.6
Current year 31.55
Extreme 31.55
37.65
1 year 31.55
Extreme 31.55
37.65
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Chief Executive Officer - 05/11/2020
Director of Finance/CFO - 07/03/2014
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 27/05/2016
Chairman - 05/11/2020
Director/Board Member - 17/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.24%+1.18%+2.39% - 157M
+1.72%+1.85%+13.68%+63.06% 45.94B
-1.02%-1.90%+36.59%+101.89% 37.22B
+0.09%+5.64%+12.10%+88.58% 12.06B
-0.60%+2.60%-10.12%+14.90% 11.74B
-0.95%0.00%+19.27%+142.99% 9.03B
-0.23%+1.91%+27.62%+41.75% 7.36B
+0.11%+3.30%+21.42%+196.00% 7.2B
-0.06%+2.97%+39.67%-17.58% 7.15B
+0.70%+1.10%-41.96%+7.80% 5.03B
Average +0.20%+1.14%+12.06%+71.04% 14.29B
Weighted average by Cap. +0.20%+0.23%+18.35%+76.05%

Financials

2024 2025
Net sales 8.92B 280M 244M 231M 210M 393M 26.89B 394M 2.76B 1.07B 13.67B 1.05B 1.03B 43.99B 8.57B 269M 235M 222M 201M 377M 25.84B 379M 2.66B 1.02B 13.14B 1.01B 989M 42.27B
Net income 317M 9.97M 8.69M 8.21M 7.45M 13.97M 957M 14.03M 98.34M 37.95M 486M 37.46M 36.62M 1.57B 300M 9.43M 8.22M 7.76M 7.05M 13.21M 905M 13.26M 92.98M 35.88M 460M 35.42M 34.63M 1.48B
Net Debt 2.46B 77.2M 67.32M 63.56M 57.72M 108M 7.41B 109M 761M 294M 3.77B 290M 284M 12.12B 2.26B 70.9M 61.82M 58.38M 53.01M 99.32M 6.8B 99.73M 699M 270M 3.46B 266M 260M 11.13B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
20/09/26 NT$34.25 +2.24% 13,173
18/09/26 NT$33.50 -1.33% 2,721,173
17/09/26 NT$33.95 +0.74% 229,108
16/09/26 NT$33.70 0.00% 189,509
15/09/26 NT$33.70 -0.44% 220,294
  1. Stock Market
  2. Stocks
  3. 3716 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!